ETF Channel
Market News Video Self Directed Investor The Warren Buffetts Next Door Stock message boards Portfolio Channel
VVUS Description — Vivus, Inc.

VIVUS is a biopharmaceutical company. Co.'s drug Qsymia (phentermine and topiramate extended-release) is an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol (dyslipidemia). Co.'s drug STENDRA, or avanafil, is an oral phosphodiesterase type 5, inhibitor that Co. has licensed from Mitsubishi Tanabe Pharma Corporation, for the treatment of erectile dysfunction.

Company Name:  Vivus, Inc.
Website:  www.vivus.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding VVUS:  15
Total Market Value Held by ETFs:  $7,923,211
Total Market Capitalization:  $118,000,000
% of Market Cap. Held by ETFs:  6.71%
 ETF   VVUS Weight   VVUS Amount 
 IHE   0.28%   $3,163,620         
 IWM   0.01%   $1,738,549         
 IBB   0.02%   $1,558,688         
 IWO   0.01%   $910,803         
 IWC   0.03%   $282,705         
 VB   0.00%   $189,115         
 IWV   0.00%   $30,978         
 PXSG   0.05%   $16,280         
 EWRS   0.02%   $8,777         
 DSI   0.00%   $8,621         
List of all 15 ETFs holding VVUS »
10 ETFs With Stocks That Insiders Are Buying
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs
The Top 10 DividendRank'ed Stocks
The DividendRank Top 25
The Top 10 DividendRank'ed DJIA Components
The Top 10 DividendRank'ed Dow Transports Components
The Top 10 DividendRank'ed Dow Utilities Components
The Top 10 DividendRank'ed Nasdaq 100 Components
10 Stocks Going Ex-Dividend
10 Oversold Dividend Stocks
10 Stocks Where Yields Got More Juicy
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Top Ranked Dividend Stocks With Insider Buying
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Metals Stocks You Can Buy Cheaper Than Insiders Did
10 Oversold Metals Stocks
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Oversold Energy Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
10 Stocks Crossing Below Book Value
10 Stocks Crossing Above Their 200 Day Moving Average
10 Stocks Crossing Below Their 200 Day Moving Average
10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
Top 10 Analyst Rated Consumer Stocks
Top 10 Analyst Rated Dividend Stocks
Top 10 Analyst Rated Energy Stocks
Top 10 Analyst Rated Financial Stocks
Top 10 Analyst Rated Healthcare Stocks
Top 10 Analyst Rated REIT Stocks
Top 10 Analyst Rated Technology Stocks
The Top 10 DividendRank'ed Canadian Stocks
The DividendRank Canada Top 25
10 Canadian Stocks Going Ex-Dividend
10 Oversold Canadian Stocks
10 Canadian Stocks Where Yields Got More Juicy
10 Must-Know High-Yield Canadian Real Estate Stocks
10 Top DividendRank'ed Canadian Financials
10 Must-Know High-Yield Canadian Energy Stocks
10 Canadian Stocks Crossing Below Book Value
10 Canadian Stocks Crossing Above Their 200 Day Moving Avg
10 Canadian Stocks Crossing Below Their 200 Day Moving Avg
Stock market game
Quotes delayed 20 minutes

Hold (2.00 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite


PARTNER NEWS:

Fri, Aug 14, 3:04 PM, Zacks
Stocks Trading Near Their 52-Week Lows: 4 Hot Picks
The low valuation of these stocks serves as the perfect opportunity for investors to get on board, purchase them and ride the anticipated growth trend.

Thu, Aug 13, 7:18 AM, Zacks
VIVUS Inc. (VVUS) in Focus: Stock Jumps 5.4%
VIVUS Inc. (VVUS) was a big mover last session, as the company saw its shares rise over 5% on the day.

ETFs Holding VVUS | Vivus, Inc. | ETF Channel | www.ETFChannel.com | Copyright © 2009 - 2015, All Rights Reserved

Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.